156 related articles for article (PubMed ID: 32690656)
1. NRF2 Augments Epidermal Antioxidant Defenses and Promotes Atopy.
Ogawa T; Ishitsuka Y; Nakamura Y; Kubota N; Saito A; Fujisawa Y; Watanabe R; Okiyama N; Suga Y; Roop DR; Fujimoto M
J Immunol; 2020 Aug; 205(4):907-914. PubMed ID: 32690656
[TBL] [Abstract][Full Text] [Related]
2. Nrf2 Involvement in Chemical-Induced Skin Innate Immunity.
Helou DG; Martin SF; Pallardy M; Chollet-Martin S; Kerdine-Römer S
Front Immunol; 2019; 10():1004. PubMed ID: 31134077
[TBL] [Abstract][Full Text] [Related]
3. Aberrant distribution patterns of corneodesmosomal components of tape-stripped corneocytes in atopic dermatitis and related skin conditions (ichthyosis vulgaris, Netherton syndrome and peeling skin syndrome type B).
Igawa S; Kishibe M; Honma M; Murakami M; Mizuno Y; Suga Y; Seishima M; Ohguchi Y; Akiyama M; Hirose K; Ishida-Yamamoto A; Iizuka H
J Dermatol Sci; 2013 Oct; 72(1):54-60. PubMed ID: 23810772
[TBL] [Abstract][Full Text] [Related]
4. Injury, dysbiosis, and filaggrin deficiency drive skin inflammation through keratinocyte IL-1α release.
Archer NK; Jo JH; Lee SK; Kim D; Smith B; Ortines RV; Wang Y; Marchitto MC; Ravipati A; Cai SS; Dillen CA; Liu H; Miller RJ; Ashbaugh AG; Uppal AS; Oyoshi MK; Malhotra N; Hoff S; Garza LA; Kong HH; Segre JA; Geha RS; Miller LS
J Allergy Clin Immunol; 2019 Apr; 143(4):1426-1443.e6. PubMed ID: 30240702
[TBL] [Abstract][Full Text] [Related]
5. Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis.
Nakayama T; Fujisawa R; Yamada H; Horikawa T; Kawasaki H; Hieshima K; Izawa D; Fujiie S; Tezuka T; Yoshie O
Int Immunol; 2001 Jan; 13(1):95-103. PubMed ID: 11133838
[TBL] [Abstract][Full Text] [Related]
6. Keratinocytes: innate immune cells in atopic dermatitis.
Chieosilapatham P; Kiatsurayanon C; Umehara Y; Trujillo-Paez JV; Peng G; Yue H; Nguyen LTH; Niyonsaba F
Clin Exp Immunol; 2021 Jun; 204(3):296-309. PubMed ID: 33460469
[TBL] [Abstract][Full Text] [Related]
7. Genetic activation of Nrf2 reduces cutaneous symptoms in a murine model of Netherton syndrome.
Muzumdar S; Koch M; Hiebert H; Bapst A; Gravina A; Bloch W; Beer HD; Werner S; Schäfer M
Dis Model Mech; 2020 Jun; 13(5):. PubMed ID: 32457102
[TBL] [Abstract][Full Text] [Related]
8. The cutaneous innate immune response in patients with atopic dermatitis.
Kuo IH; Yoshida T; De Benedetto A; Beck LA
J Allergy Clin Immunol; 2013 Feb; 131(2):266-78. PubMed ID: 23374259
[TBL] [Abstract][Full Text] [Related]
9. Epidermal tight junction barrier function is altered by skin inflammation, but not by filaggrin-deficient stratum corneum.
Yokouchi M; Kubo A; Kawasaki H; Yoshida K; Ishii K; Furuse M; Amagai M
J Dermatol Sci; 2015 Jan; 77(1):28-36. PubMed ID: 25511077
[TBL] [Abstract][Full Text] [Related]
10. Deletion of NRF2 disturbs composition, morphology, and differentiation of the murine tail epidermis in chronological aging.
Sochorová M; Kremslehner C; Nagelreiter IM; Ferrara F; Lisicin MM; Narzt MS; Bauer C; Stiegler A; Golabi B; Vávrová K; Gruber F
Biofactors; 2023; 49(3):684-698. PubMed ID: 36772996
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-143 inhibits IL-13-induced dysregulation of the epidermal barrier-related proteins in skin keratinocytes via targeting to IL-13Rα1.
Zeng YP; Nguyen GH; Jin HZ
Mol Cell Biochem; 2016 May; 416(1-2):63-70. PubMed ID: 27048505
[TBL] [Abstract][Full Text] [Related]
12. Nrf2 links epidermal barrier function with antioxidant defense.
Schäfer M; Farwanah H; Willrodt AH; Huebner AJ; Sandhoff K; Roop D; Hohl D; Bloch W; Werner S
EMBO Mol Med; 2012 May; 4(5):364-79. PubMed ID: 22383093
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Proteomics Identifies Reduced NRF2 Activity and Mitochondrial Dysfunction in Atopic Dermatitis.
Koch M; Kockmann T; Rodriguez E; Wehkamp U; Hiebert P; Ben-Yehuda Greenwald M; Stölzl D; Beer HD; Tschachler E; Weidinger S; Werner S; Auf dem Keller U
J Invest Dermatol; 2023 Feb; 143(2):220-231.e7. PubMed ID: 36108803
[TBL] [Abstract][Full Text] [Related]
14. Peeling off the genetics of atopic dermatitis-like congenital disorders.
Samuelov L; Sprecher E
J Allergy Clin Immunol; 2014 Oct; 134(4):808-15. PubMed ID: 25282561
[TBL] [Abstract][Full Text] [Related]
15. Conditional knock out of N-WASP in keratinocytes causes skin barrier defects and atopic dermatitis-like inflammation.
Kalailingam P; Tan HB; Jain N; Sng MK; Chan JSK; Tan NS; Thanabalu T
Sci Rep; 2017 Aug; 7(1):7311. PubMed ID: 28779153
[TBL] [Abstract][Full Text] [Related]
16. Th1 cytokines accentuate but Th2 cytokines attenuate ceramide production in the stratum corneum of human epidermal equivalents: an implication for the disrupted barrier mechanism in atopic dermatitis.
Sawada E; Yoshida N; Sugiura A; Imokawa G
J Dermatol Sci; 2012 Oct; 68(1):25-35. PubMed ID: 22884781
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the immune response to contact sensitizers by Nrf2.
Vallion R; Kerdine-Römer S
Contact Dermatitis; 2022 Jul; 87(1):13-19. PubMed ID: 35165896
[TBL] [Abstract][Full Text] [Related]
18. Adhesion molecules in atopic dermatitis: upregulation of alpha6 integrin expression in spontaneous lesional skin as well as in atopen, antigen and irritative induced patch test reactions.
Jung K; Imhof BA; Linse R; Wollina U; Neumann C
Int Arch Allergy Immunol; 1997 Aug; 113(4):495-504. PubMed ID: 9250597
[TBL] [Abstract][Full Text] [Related]
19. Epidermal Overexpression of Xenobiotic Receptor PXR Impairs the Epidermal Barrier and Triggers Th2 Immune Response.
Elentner A; Schmuth M; Yannoutsos N; Eichmann TO; Gruber R; Radner FPW; Hermann M; Del Frari B; Dubrac S
J Invest Dermatol; 2018 Jan; 138(1):109-120. PubMed ID: 28927887
[TBL] [Abstract][Full Text] [Related]
20. Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Regulates Epidermal Keratinization under Psoriatic Skin Inflammation.
Ogawa T; Ishitsuka Y; Inoue S; Nakamura Y; Saito A; Okiyama N; Fujisawa Y; Furuta J; Watanabe R; Fujimoto M
Am J Pathol; 2020 Mar; 190(3):577-585. PubMed ID: 31953037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
